Humacyte Shares Rise After FDA Grants Priority Review to Vascular Trauma Treatment

By Kailyn Rhone Shares of Humacyte rose after the U.S. Food and Drug Administration granted priority review to its vascular trauma treatment in development....

Related Keywords

Kailyn Rhone ,Laura Niklason ,Drug Administration ,Human Acellular Vessel ,Executive Laura Niklason ,Article Normal ,Biotechnology Services ,Healthcare Life Sciences ,Equity Markets ,Commodity Financial Market News ,Content Types ,Factiva Filters ,C Amp Ampe Exclusion Filter ,Synd ,Humacyte ,Huma ,Us44486q1031 ,Commodity ,Financial Market News ,Healthcare ,Life Sciences ,